(Q45889300)

17 December 2017

title

Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine (English)

1 reference

17 December 2017

author name string

Yei S

1

1 reference

17 December 2017

Bartholomew RM

2

1 reference

17 December 2017

Pezzoli P

3

1 reference

17 December 2017

Gutierrez A

4

1 reference

17 December 2017

Gouveia E

5

1 reference

17 December 2017

Bassett D

6

1 reference

17 December 2017

Soo Hoo W

7

1 reference

17 December 2017

Carlo DJ

8

1 reference

17 December 2017

publication date

1 October 2002

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

9

1 reference

17 December 2017

issue

19

1 reference

17 December 2017

page(s)

1302-1311

1 reference

17 December 2017

Cytokine-secreting tumor cell vaccines

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

The dendritic cell system and its role in immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

Physiology and pathophysiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

Understanding the dendritic cell lineage through a study of cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

Novel fold and putative receptor binding site of granulocyte-macrophage colony-stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

Adoptive immunotherapy of cancer with activated lymph node cells primed in vivo with autologous tumor cells transduced with the GM-CSF gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

7 January 2021

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

7 January 2021

Stimulation of [3H]thymidine uptake in mouse marrow by granulocyte-macrophage colony stimulating factor from mouse lung conditioned medium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

7 January 2021

Selection of Successive Tumour Lines for Metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

7 January 2021

Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301803

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301803

1 reference

17 December 2017

Dimensions Publication ID

1029140731

0 references

1 reference

17 December 2017